Clinical Trial Update: Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients [Phase 2]

View source ↗

Summary

Late cardiac safety evaluation results from a three-arm Belgian Phase 2 trial in node-positive early breast cancer are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Jules Bordet Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED